Donanemab and lecanemab are targeted antibody drugs that slow down the early stages of Alzheimer’s. They represent a huge ...

Optical coherence tomography markers—like the ellipsoid zone—are reshaping clinical trials in intermediate age-related ...

Fact checked by Nick Blackmer Clinical trials are a testing phase for drugs, devices, and procedures. These research studies ...

It is not enough to enhance efficiency or accuracy; we must embed transparency, temporal awareness and systemic oversight ...

Surya Gummadi, president of Cognizant Americas, discusses the transformative impact of AI in health care, emphasizing ...

Catching the flu or COVID can trigger a heart attack or stroke in vulnerable people. Here’s what we can all do to lower our ...

Knowable Magazine shares how studies show psychological strain can accelerate tumors and asks if beta blockers slow them down ...

The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug ...

Dr. Bruce Chabner explains how clinical trials pave the way for new treatments and the benefits of participating in one.

A Seattle infectious disease doctor, whose work was pivotal early in the COVID pandemic, shares more on her experience with ...

A drug called lenacapavir, administered in two injections a year, offers protection from HIV comparable to daily pills. One ...

Experts and advocates say that twice-a-year HIV PrEP injections have the prevention potential of a vaccine — and that a once-a-year version of lenacapavir would be even better. But will Yeztugo be ...